Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Preaxia Health Care Payment Systems (PAXH) EBITDA (2019 - 2025)

Preaxia Health Care Payment Systems' EBITDA history spans 7 years, with the latest figure at -$874906.0 for Q3 2025.

  • For Q3 2025, EBITDA fell 18808.71% year-over-year to -$874906.0; the TTM value through Aug 2025 reached -$906662.0, down 1335.57%, while the annual FY2025 figure was -$79782.0, 19.78% up from the prior year.
  • EBITDA for Q3 2025 was -$874906.0 at Preaxia Health Care Payment Systems, down from -$13463.0 in the prior quarter.
  • Across five years, EBITDA topped out at -$4611.0 in Q2 2024 and bottomed at -$874906.0 in Q3 2025.
  • The 5-year median for EBITDA is -$40317.0 (2021), against an average of -$79108.9.
  • The largest annual shift saw EBITDA surged 88.69% in 2024 before it tumbled 18808.71% in 2025.
  • A 5-year view of EBITDA shows it stood at -$43655.0 in 2021, then fell by 3.29% to -$45092.0 in 2022, then dropped by 0.04% to -$45109.0 in 2023, then soared by 69.7% to -$13666.0 in 2024, then plummeted by 6302.06% to -$874906.0 in 2025.
  • Per Business Quant, the three most recent readings for PAXH's EBITDA are -$874906.0 (Q3 2025), -$13463.0 (Q1 2025), and -$13666.0 (Q4 2024).